Obstructive sleep apnea syndrome (OSAS) is a condition which causes recurrent respiratory dysfunction (apnea, hypopnea) during sleep because of the obstruction of the upper respiratory tract and is a significant health problem that may affect various systems of the body (1). Although the pathogenesis of OSAS is not known, it might stem from many other causes, including differing mechanisms like inflammation and oxidative stress (2). While obesity is one of the primary factors, agedness, male gender, ethnic origin, and family history are among other risk factors (1). The data published in the literature emphasizes the relationship between OSAS and a variety of impairments including cardiovascular diseases, ABSTRACT Introduction: The aim of this study was to assess vitamin D levels in obstructive sleep apnea syndrome (OSAS) and whether there is a relationship between the severity of the disease and vitamin D. Materials and Methods: In this retrospective study, demographic data, serum 25-Hydroxycholecalciferol [25 (OH) D3], parathyroid hormone (PTH), calcium (Ca), phosphate (P), magnesium (Mg) levels and disease severity [mild, moderate and severe OSAS (AHI = 5-15, 16-30,> 30 / hour)] of patients diagnosed with OSAS by using polysomnography [apnea-hypopnea index (AHI> 5/hour] and normal patients (AHI <5/hour)] were evaluated based on hospital records. Results: Of the 293 subjects whose records were examined, 229 had OSAS (mean age 55.7 ± 11.3 years; age range 26-86 years), whereas 64 subjects were normal (mean age 55.4 ± 13.7 years; age range 24-78 years). 25 (OH) D3 level was significantly lower while BMI and PTH levels were higher in OSAS patients compared to the control group (p <0.05). 25 (OH) D3 levels were significantly lower in patients with severe OSAS (p <0.05). In addition, there was a weak negative relationship between AHI and 25 (OH) D3 (p: 0.001, r:-0.328), while a weak positive relationship was observed between PTH (p: 0.001, r: 0.186) and BMI (p: 0.001, r: 0.208). Conclusion: OSAS patients have vitamin D deficiency, and patients especially with severe OSAS have lower vitamin D deficiency. Therefore, We think that making up of vitamin D deficiency in these patients may be beneficial in reducing the severity of the disease.